反应详情

7-[[5-(Morpholin-4-yl)methylpyridin-3-yl]hydroxymethyl]imidazo[5,1-b]thiazole (384 mg) was prepared in substantially the same manner as in step a) of Synthesis Example 5, except that 1.05 g of 4-(5-bromopyridin-3-yl)methylmorpholine, 2.70 ml of a 1.59 N nbutyllithium/n-hexane solution, and 426 mg of 7-formylimidazo[5,1-b]thiazole were used as the starting materials.

1. customof Synthesis Example 5